Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
15 participants
INTERVENTIONAL
2021-01-15
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
NCT00946660
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
NCT01437293
Impact of a Non-Drug Choice on Cocaine Reinforcement
NCT01906346
The Effect of Glutamatergic Modulation on Cocaine Self-administration
NCT02596022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
$0.25 alternative reinforcer value
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and an alternative monetary reinforcer are available during each trial. Each money value is tested in a separate session.
Money
Three money values offered as alternatives to cocaine.
Cocaine HCl
3 mg/70 kg is available as an alternative to money.
$1.00 alternative reinforcer value
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and an alternative monetary reinforcer are available during each trial. Each money value is tested in a separate session.
Money
Three money values offered as alternatives to cocaine.
Cocaine HCl
3 mg/70 kg is available as an alternative to money.
$4.00 alternative reinforcer value
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and an alternative monetary reinforcer are available during each trial. Each money value is tested in a separate session.
Money
Three money values offered as alternatives to cocaine.
Cocaine HCl
3 mg/70 kg is available as an alternative to money.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Money
Three money values offered as alternatives to cocaine.
Cocaine HCl
3 mg/70 kg is available as an alternative to money.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Joshua A. Lile, Ph.D.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joshua A. Lile, Ph.D.
Professor of Behavioral Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Lile, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratory of Human Behavioral Pharmacology
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BED(In)(41)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.